BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11445546)

  • 1. Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis.
    Schuette CG; Pierstorff B; Huettler S; Sandhoff K
    Glycobiology; 2001 Jun; 11(6):81R-90R. PubMed ID: 11445546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.
    Kolter T; Sandhoff K
    Annu Rev Cell Dev Biol; 2005; 21():81-103. PubMed ID: 16212488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activator proteins and topology of lysosomal sphingolipid catabolism.
    Fürst W; Sandhoff K
    Biochim Biophys Acta; 1992 Jun; 1126(1):1-16. PubMed ID: 1606169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunological functions of saposins.
    Darmoise A; Maschmeyer P; Winau F
    Adv Immunol; 2010; 105():25-62. PubMed ID: 20510729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
    Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
    FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids and lysosomal pathologies.
    Schulze H; Sandhoff K
    Biochim Biophys Acta; 2014 May; 1841(5):799-810. PubMed ID: 24184515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
    Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
    J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
    Sandhoff K; Kolter T; Van Echten-Deckert G
    Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins.
    Ferlinz K; Linke T; Bartelsen O; Weiler M; Sandhoff K
    Chem Phys Lipids; 1999 Nov; 102(1-2):35-43. PubMed ID: 11001559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
    Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
    Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin.
    Lefrancois S; Zeng J; Hassan AJ; Canuel M; Morales CR
    EMBO J; 2003 Dec; 22(24):6430-7. PubMed ID: 14657016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
    Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
    J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
    Sandhoff K
    Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid activator proteins are required for epidermal permeability barrier formation.
    Doering T; Holleran WM; Potratz A; Vielhaber G; Elias PM; Suzuki K; Sandhoff K
    J Biol Chem; 1999 Apr; 274(16):11038-45. PubMed ID: 10196186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids.
    Ciaffoni F; Tatti M; Salvioli R; Vaccaro AM
    Biochem J; 2003 Aug; 373(Pt 3):785-92. PubMed ID: 12733985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
    Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
    Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
    Sandhoff K; Klein A
    FEBS Lett; 1994 Jun; 346(1):103-7. PubMed ID: 8206147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.